3-Iodo-4-methyl-1H-pyrrolo[2,3-c]pyridine
95%
- Product Code: 200677
CAS:
1190318-68-3
Molecular Weight: | 258.06 g./mol | Molecular Formula: | C₈H₇IN₂ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12963330 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | 2-8°C, sealed, dry, light-proof |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure supports the development of compounds with high selectivity toward specific signaling pathways involved in tumor growth. Also employed in the preparation of novel heterocyclic compounds for drug discovery programs focusing on oncology and inflammatory diseases. Suitable for coupling reactions in medicinal chemistry due to the presence of reactive iodine functionality.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | $307.95 |
+
-
|
250mg | 10-20 days | $522.93 |
+
-
|
1g | 10-20 days | $1,411.42 |
+
-
|
3-Iodo-4-methyl-1H-pyrrolo[2,3-c]pyridine
Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly for targeted cancer therapies. Its structure supports the development of compounds with high selectivity toward specific signaling pathways involved in tumor growth. Also employed in the preparation of novel heterocyclic compounds for drug discovery programs focusing on oncology and inflammatory diseases. Suitable for coupling reactions in medicinal chemistry due to the presence of reactive iodine functionality.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :